Avycaz

Chemical Nameceftazidime-avibactam
Dosage FormInjection (intravenous; 2 g ceftazidime-0.5 g avibactam)
Drug ClassInhibitors
SystemDigestive, Urinary, Respiratory
CompanyAllergan
Approval Year2015

Indication

  • For the treatment of the following infections caused by designated susceptible Gram-negative microorganisms: Complicated Intra-abdominal Infections (cIAI), used in combination with metronidazole, in adult and pediatric patients 3 months and older or complicated Urinary Tract Infections (cUTI), including Pyelonephritis, in adult and pediatric patients 3 months and older or hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia (HABP/VABP) in patients 18 years and older.
Last updated on 10/27/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Avycaz (ceftazidime and avibactam) Prescribing Information 2019Allergan USA, Inc., Madison, NJ